COVID-19 in persons with multiple sclerosis treated with ocrelizumab: Pharmacovigilance update

Authors
Category Primary study
JournalMultiple Sclerosis Journal
Year 2020
This article has no abstract
Epistemonikos ID: 8eefafb165e6dfbc35c01a6756245b7151296923
First added on: Feb 12, 2025